Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC
Lee, Stephanie W.
Romano, John L.
MetadataShow full item record
CitationAgrawal, V., T. P. Coroller, Y. Hou, S. W. Lee, J. L. Romano, E. H. Baldini, A. B. Chen, et al. 2017. “Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC.” PLoS ONE 12 (4): e0174268. doi:10.1371/journal.pone.0174268. http://dx.doi.org/10.1371/journal.pone.0174268.
AbstractBackground: Locally advanced non-small cell lung cancer (LA-NSCLC) patients have poorer survival and local control with mediastinal node (N2) tumor involvement at resection. Earlier assessment of nodal burden could inform clinical decision-making prior to surgery. This study evaluated the association between clinical outcomes and lymph node volume before and after neoadjuvant therapy. Materials and methods CT imaging of patients with operable LA-NSCLC treated with chemoradiation and surgical resection was assessed. Clinically involved lymph node stations were identified by FDG-PET or mediastinoscopy. Locoregional recurrence (LRR), distant metastasis (DM), progression free survival (PFS) and overall survival (OS) were analyzed by the Kaplan Meier method, concordance index and Cox regression. Results: 73 patients with Stage IIIA-IIIB NSCLC treated with neoadjuvant chemoradiation and surgical resection were identified. The median RT dose was 54 Gy and all patients received concurrent chemotherapy. Involved lymph node volume was significantly associated with LRR and OS but not DM on univariate analysis. Additionally, lymph node volume greater than 10.6 cm3 after the completion of preoperative chemoradiation was associated with increased LRR (p<0.001) and decreased OS (p = 0.04). There was no association between nodal volumes and nodal clearance. Conclusion: For patients with LA-NSCLC, large volume nodal disease post-chemoradiation is associated with increased risk of locoregional recurrence and decreased survival. Nodal volume can thus be used to further stratify patients within the heterogeneous Stage IIIA-IIIB population and potentially guide clinical decision-making.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:33029735
- HMS Scholarly Articles